Rigel Pharmaceuticals
The Territory Business Manager is responsible for delivering sustained business performance across a hematology/oncology portfolio, with a primary focus on metastatic breast cancer and additional responsibilities for r/r AML and cITP. This role involves developing and executing an integrated territory strategy to advance patient identification, expand customer access, and drive results across community oncology and hematology practices. The position requires deep breast cancer experience and the ability to operate as the owner of a complex business while maintaining compliance standards.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
1996
Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, developing, and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. The company markets approved products including TAVALISSE, REZLIDHIA, and Gavreto, and maintains a pipeline of clinical programs including IRAK1/4 and RIPK1 inhibitors. Rigel is publicly traded under the ticker RIGL and is headquartered in South San Francisco, California.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rigel Pharmaceuticals.
79% above the average for this role